Health Condition 1: N189- Chronic kidney disease, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
KLE College of Pharmacy Belagavi
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with chronic kidney disease Stages 1-5 or those receiving dialysis. 2.Patients Taking five or more medications concurrently. 3.Adults aged 18 years or older. 4.Patients Who Provide Informed Consent to Participate in the study. 5.Referred Patients are included
Exclusion criteria
Exclusion criteria: 1.Patients with Cognitive impairment that prevents from completing surveys or providing Informed Consent. 2.Patients who are not willing to provide consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| •To Evaluate the effect of Polypharmacy on disease status in Patients with Chronic Kidney Disease.Timepoint: One-time assessment at the time of enrollment. | — |
Secondary
| Measure | Time frame |
|---|---|
| •To assess and evaluate the effect of Polypharmacy on Quality of Life in Chronic Kidney Disease Patients using Medication Related Quality of Life (MRQOL).Timepoint: One-time assessment at the time of enrollment.;•To assess and report the adverse events in Patients with Chronic Kidney Disease.Timepoint: One-time assessment at the time of enrollment. | — |
Countries
India
Contacts
Public ContactGeetanjali S Salimath
KLE College of Pharmacy BelagavikLE College of Pharmacy Belagavi
Outcome results
None listed